- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01379313
The Effect of Different I:E Ratio on Gas Exchange of Patients Undergoing Gynecologic Laparoscopic Surgery With Trendelenburg Position
September 27, 2012 updated by: Tae Soo Hahm, Samsung Medical Center
In patients undergoing gynecologic laparoscopic surgery with trendelenburg position, the disturbance of pulmonary gas exchange frequently occurs due to high intra-abdominal pressure.
The investigators tried to evaluate the effect of various inspiratory to expiratory ratio on pulmonary gas exchange by randomized controlled trial.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
In patients undergoing gynecologic laparoscopic surgery with trendelenburg position, the disturbance of pulmonary gas exchange frequently occurs due to high intra-abdominal pressure.
During the laparoscopic surgery with abdominal gas insufflation, gas exchange disturbance such as CO2 retention, hypoxemia occurs in addition to high plateau airway pressure.
The usual strategy against these kinds of problem is pressure-controlled ventilation.
However, the gas exchange problem especially CO2 retention can not be solved in some cases.
The inverse-ratio ventilation (IRV), which prolongs the inspiratory time greater than expiratory time, can be applied for adult respiratory distress syndrome.
The efficacy of IRV is to improve gas-exchange status by increasing mean airway pressure and alveolar recruitment.
There have been several clinical investigations which applied IRV during general anesthesia.
However, there have been debates about the effect of IRV during general anesthesia.
Therefore, we tried to apply the IRV for subjects undergoing laparoscopic surgery, and evaluate the effect of different I:E ratio on the pulmonary gas exchange and respiratory mechanics.
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 135-710
- Samsung Seoul Hospital, Samsung Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients undergoing elective gynecologic laparoscopic surgery
- the duration of pneumoperitoneum during laparoscopic surgery is more than 40 minutes
Exclusion Criteria:
- ASA (American society of anesthesiologists) classification of the subjects more than III.
- Age under 20, or more than 65 years.
- Past history of pneumothorax, COPD, asthma.
- Patients with ischemic heart disease, valvular heart disease.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: 1:2 group
conventional I:E ratio group, inspiratory time : expiratory time = 1:1
|
conventional I:E ratio of 1:2 is applied.
|
Experimental: 1:1 group
1:1 I:E ratio group, inspiratory time : expiratory time = 1:1
|
I:E ratio of 1:1 is applied.
|
Experimental: 2:1 group
inverse ratio group, inspiratory time : expiratory time = 2:1
|
Inverse I:E ratio of 2:1 is applied.
|
Active Comparator: 1:2 PEEP group
I:E ratio of 1:2 with external PEEP of 5 cm H2O
|
conventional I:E ratio of 1:2 is applied.
external positive end-expiratory pressure of 5 cmH2O is applied.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
arterial CO2 partial pressure
Time Frame: 10 minutes after induction of general anesthesia
|
arteial CO2 partial pressure
|
10 minutes after induction of general anesthesia
|
arterial CO2 partial pressure
Time Frame: 30 minutes after start of pneumoperitoneum
|
arteial CO2 partial pressure
|
30 minutes after start of pneumoperitoneum
|
arterial CO2 partial pressure
Time Frame: 60 minutes after start of pneumoperitoneum
|
arteial CO2 partial pressure
|
60 minutes after start of pneumoperitoneum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
arterial O2 partial pressure
Time Frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
arterial O2 partial pressure
|
10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
Mean airway pressure
Time Frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
Mean airway pressure
|
10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
tidal volume (setting)
Time Frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
tidal volume (setting)
|
10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
hemodynamic parameters
Time Frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
systolic/ diastolic blood pressure, heart rate, mean blood pressure
|
10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
end-tidal CO2 partial pressure
Time Frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
end-tidal CO2 partial pressure
|
10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
respiratory compliance
Time Frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
Dynamic compliance, Static compliance
|
10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
Dead space
Time Frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
physiologic dead space / tidal volume (VD/VT)
|
10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
work of breathing
Time Frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
work of breathing
|
10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
peak inspiratory pressure
Time Frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
peak inspiratory pressure
|
10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
plateau pressure
Time Frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
plateau pressure
|
10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
positive end-expiratory pressure
Time Frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
positive end-expiratory pressure
|
10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
tidal volume (exhaled)
Time Frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
tidal volume (exhaled)
|
10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
minute ventilation
Time Frame: 10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
minute ventilation
|
10 min after induction, 30 and 60 min after start of pneumoperitoneum
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Tae Soo Hahm, M.D.,Ph.D., Samsung Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2011
Primary Completion (Actual)
March 1, 2012
Study Completion (Actual)
March 1, 2012
Study Registration Dates
First Submitted
June 21, 2011
First Submitted That Met QC Criteria
June 22, 2011
First Posted (Estimate)
June 23, 2011
Study Record Updates
Last Update Posted (Estimate)
October 1, 2012
Last Update Submitted That Met QC Criteria
September 27, 2012
Last Verified
September 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2011-04-007
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Uterine Myoma
-
Ospedale Policlinico San MartinoRecruitingUterine Fibroids | Uterine MyomasItaly
-
PregLem SACompletedUterine MyomasCzech Republic, Hungary, India, Romania, Russian Federation, Ukraine
-
PregLem SACompletedUterine MyomasSpain, Germany, Austria, Israel, Poland, Italy, Belgium, France, Netherlands
-
University Magna GraeciaJohnson & JohnsonCompleted
-
Far Eastern Memorial HospitalRecruiting
-
University of CagliariAzienda Ospedaliera Ordine Mauriziano di Torino; University of Foggia; Civic... and other collaboratorsRecruiting
-
Taipei Veterans General Hospital, TaiwanUnknownMyoma | AdenomyosisTaiwan
-
Samsung Medical CenterUnknownUterine Adenomyosis | Uterine MyomaKorea, Republic of
-
Brugmann University HospitalWithdrawnSymptomatic Submucosal MyomaBelgium, France
-
Hallym University Kangnam Sacred Heart HospitalCompletedUterine Cancer | Uterus MyomaKorea, Republic of
Clinical Trials on conventional I:E ratio
-
Yonsei UniversityCompletedGeneral Anesthesia Using Endotracheal IntubationKorea, Republic of
-
Samsung Medical CenterCompletedLung Cancer | One Lung Ventilation | Gas Exchange | Inverse-ratio VentilationKorea, Republic of
-
Gangnam Severance HospitalCompletedBlood Loss, SurgicalKorea, Republic of
-
Yonsei UniversityCompletedObese Patients, One Lung VentilationKorea, Republic of
-
Yonsei UniversityCompletedLung Cancer | Lung LobectomyKorea, Republic of
-
Gachon University Gil Medical CenterCompletedColorectal NeoplasmsKorea, Republic of
-
IRCCS Burlo GarofoloCompletedHematopoietic Stem Cell TransplantationItaly
-
Ain Shams UniversityUnknown
-
RenJi HospitalCompletedPlatelet Count/Spleen Diameter Ratio | Child-Pugh ClassificationChina
-
Turku University HospitalNordic Urothelial Cancer GroupRecruitingBladder Cancer | Invasive Bladder CancerFinland